Alignment Healthcare, Inc. (ALHC) Stock Analysis
Healthcare · Healthcare Plans · NasdaqGS
Alignment Healthcare, Inc. (ALHC) posted $3.95B in revenue for fiscal 2025 (up 46.1% year over year), with a net loss of $724,000, and has compounded revenue about 32.7%/yr over five years, per its SEC filings.
Data last refreshed August 2, 2026 from SEC filings · how we compute this
The analyst's take on Alignment Healthcare, Inc.
Alignment Healthcare, Inc. has grown revenue from $756.96M to $3.95B over the last 7 fiscal years, compounding about 32.7% a year. The most recent year was up 46.1%, so growth is actually accelerating.
Net margin sits at 0%, up 4.7 points year over year. It carries about $323.18M of total debt.
At today's valuation the market is pricing in roughly 16.3% annual free-cash-flow growth. The one thing worth a second look in the filings is receivables growing faster than sales.
Synthesised from Alignment Healthcare, Inc.'s SEC filings — descriptive, not advice. Ask the analyst your own question →
Alignment Healthcare, Inc. revenue & earnings — last 7 fiscal years
| Metric | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Revenue | $756.96M | $959.22M | $1.17B | $1.43B | $1.82B | $2.70B | $3.95B |
| Gross profit | — | — | — | — | — | — | — |
| Net income | $-44.73M | $-22.93M | $-195.29M | $-149.55M | $-148.02M | $-128.03M | $-724,000 |
| Net margin | -5.9% | -2.4% | -16.7% | -10.4% | -8.1% | -4.7% | -0.0% |
Source: Alignment Healthcare, Inc. SEC filings (10-K).
Alignment Healthcare, Inc.: 3 potential red flags in the filings
Patterns in the filed statements worth a second look — computed and cited, not AI guesswork, and not a signal to sell. The kind of thing that hides in a 10-K.
- Receivables growing faster than salesAccounts receivable rose 64.5% while revenue rose 46.1% in the latest year — a gap that can signal looser credit terms or pulled-forward sales. Worth checking days-sales-outstanding.
- Share count rising (dilution)Shares outstanding grew 9.1% over 4 years (187.2M → 204.2M) — existing holders' stakes are being diluted.
- Currently unprofitableThe latest fiscal year was a net loss (net margin -0.0%).
What growth is priced into ALHC stock?
At today's market cap of $4.25B, Alignment Healthcare, Inc. is priced for free-cash-flow growth of about 16.3% per year for 10 years (assuming a 10% discount rate and 2.5% terminal growth, base FCF $113.15M from the FY ending 2025-12-31). For comparison, revenue 32.7%/yr, computed from its SEC filings. This is a reverse DCF — a translation of the price into a growth assumption you can judge, not a fair value and not advice. Change the assumptions yourself in the interactive view →
Explore 7 years of Alignment Healthcare, Inc. financials — interactive
Full income statement, balance sheet and cash flow with CAGR and trend on every row, 48 quarters, valuation ratios, plain-English health checks, and Ask — our SEC-grounded research assistant.
Open the interactive view — freeOr start a 7-day free trial to track ALHC in your portfolio →
Alignment Healthcare, Inc. financial history by metric
Compare Alignment Healthcare, Inc. with peers
About Alignment Healthcare, Inc.
Alignment Healthcare, Inc. operates a consumer-centric healthcare platform for seniors in the United States. It delivers customized healthcare experience to meet the needs of seniors through its Medicare Advantage plans. Alignment Healthcare, Inc. was founded in 2013 and is based in Orange, California.
Alignment Healthcare, Inc. — frequently asked questions
What is Alignment Healthcare, Inc.'s revenue?
Alignment Healthcare, Inc. (ALHC) reported revenue of $3.95B for fiscal year 2025, up 46.1% from the prior year, according to its SEC filings.
Is Alignment Healthcare, Inc. profitable?
No — ALHC reported a net loss of $-724,000 in fiscal 2025.
What is ALHC's P/E ratio?
Alignment Healthcare, Inc. trades at a price-to-earnings ratio of about 205.7 based on the latest data in our nightly-refreshed cache.
How fast is Alignment Healthcare, Inc. growing?
ALHC's revenue grew at roughly 32.7% per year over the last five fiscal years (compound annual growth rate), computed from SEC-filed statements.
How much debt does Alignment Healthcare, Inc. have?
As of fiscal year 2025, ALHC carried roughly $323.18M in total debt (short- plus long-term borrowings), per its filed balance sheet.
What is Alignment Healthcare, Inc.'s market cap?
Alignment Healthcare, Inc. (ALHC) has a market capitalization of about $4.25B, based on the latest data in our nightly-refreshed cache.
When does Alignment Healthcare, Inc.'s fiscal year end?
ALHC's fiscal year ends in December. Its most recent annual filing covers the fiscal year ending 2025-12-31.
What growth is priced into ALHC stock?
At today's market cap of $4.25B, Alignment Healthcare, Inc. is priced for free-cash-flow growth of about 16.3% per year for 10 years (assuming a 10% discount rate and 2.5% terminal growth, base FCF $113.15M from the FY ending 2025-12-31). For comparison, revenue 32.7%/yr, computed from its SEC filings.
Where does this data come from?
All figures are computed from Alignment Healthcare, Inc.'s official SEC filings (10-K and 10-Q), covering 7 years of history, refreshed nightly. stockportfolio.pro does not provide investment advice.